Literature DB >> 34393251

[Bilateral papillary renal cell carcinoma following kidney transplantation: A case report].

P Hong1, X J Tian1, X Y Zhao1, F L Yang1, Z Liu1, M Lu2, L Zhao1, L L Ma1.   

Abstract

With the continuous development of kidney transplantation technique, the survival time after kidney transplantation is gradually prolonged. Thus, the malignant tumor has been the important influencing factor on the long-term survival for kidney transplantation patients. Renal cell carcinoma is a relatively common tumor after kidney transplantation. Besides, clear cell renal cell carcinoma and papillary renal cell carcinoma are the relatively common pathological types for renal cell carcinoma following kidney transplantation. However, bilateral renal cell carcinoma following kidney transplantation is comparatively rare. In this article, we presented a case of bilateral papillary renal cell carcinoma, which occurred after kidney transplantation. And the diagnosis and treatment were introduced in detail. The patient was 37 years old, and he underwent kidney transplantation 13 years ago in our hospital, because of kidney failure. After kidney transplantation, he had regular medical check-up every year. In this year, his urological ultrasound results indicated bilateral renal tumors. And then, he received abdominal and pelvic computed tomography, and the result also showed bilateral renal tumors, which were likely to be malignant tumors. After adequate consultation, the patient chose surgical treatment. The patient received long-term immunosuppressive therapy, because of kidney transplantation. Considering this, the surgeon decided to choose a staging surgical treatment, in order to reduce the bad influence of one-stage surgery. Then, the patient first underwent retroperitoneal laparoscopic radical nephrectomy for right renal tumor in our hospital, and he had no complications after operation. The pathological results showed papillary renal cell carcinoma. He was discharged successfully. He underwent retroperitoneal laparoscopic radical nephrectomy for left renal tumor in our hospital one month later, and he had no complications after operation. The pathological results also showed papillary renal cell carcinoma. He was discharged successfully two days after surgery. In the 3-month follow-up, the patient was recovering well. To sum up, the incidence of bilateral renal cell carcinoma following kidney transplantation is relatively rare, and bilateral radical nephrectomy is effective and safe treatment. Above all, it is the patient's condition that determines the choice of staging surgery or simultaneous surgery.

Entities:  

Keywords:  Bilateral renal cell carcinoma; Kidney transplantation; Papillary renal cell carcinoma; Surgical treatment

Mesh:

Year:  2021        PMID: 34393251      PMCID: PMC8365081     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  18 in total

1.  Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations.

Authors:  Y Hoshida; H Nakanishi; M Shin; T Satoh; J Hanai; K Aozasa
Journal:  Transplantation       Date:  1999-08-15       Impact factor: 4.939

2.  Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.

Authors:  Michael Leveridge; Mireia Musquera; Andrew Evans; Carl Cardella; York Pei; Michael Jewett; Michael Robinette; Antonio Finelli
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

3.  Malignancies after renal transplantation during 33 years at a single center.

Authors:  Gyula Végso; Mária Tóth; Márta Hídvégi; Eva Toronyi; Robert M Langer; Elek Dinya; András Tóth; Ferenc Perner; Jeno Járay
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

4.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

5.  Developments in the surgical management of sporadic synchronous bilateral renal tumours.

Authors:  William T Lowrance; David S Yee; Alexandra C Maschino; Angel M Cronin; Melanie Bernstein; R Houston Thompson; Paul Russo
Journal:  BJU Int       Date:  2009-09-14       Impact factor: 5.588

6.  Pathologic concordance of sporadic synchronous bilateral renal masses.

Authors:  Jason Rothman; Paul L Crispen; Yu-Ning Wong; Tahseen Al-Saleem; Eric Fox; Robert G Uzzo
Journal:  Urology       Date:  2008-03-12       Impact factor: 2.649

7.  Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment.

Authors:  Frank Becker; Stefan Siemer; Athanasios Tzavaras; Henrik Suttmann; Michael Stoeckle
Journal:  Urology       Date:  2008-05-15       Impact factor: 2.649

8.  Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.

Authors:  Tobias Klatte; Christian Seitz; Matthias Waldert; Michela de Martino; Zeljko Kikic; Georg A Böhmig; Andrea Haitel; Jörg Schmidbauer; Michael Marberger; Mesut Remzi
Journal:  BJU Int       Date:  2009-10-10       Impact factor: 5.588

9.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

10.  Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States.

Authors:  S Karami; E L Yanik; L E Moore; R M Pfeiffer; G Copeland; L Gonsalves; B Y Hernandez; C F Lynch; K Pawlish; E A Engels
Journal:  Am J Transplant       Date:  2016-06-23       Impact factor: 9.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.